Cell-free DNA and proteins are secreted into the bloodstream by multiple types of cancer. In a recently published prospective study involving 10,006 women, such markers were used in a cancer screening approach that incorporated PET–CT as a confirmatory test. Herein, we discuss the implications of these results.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chiu, R. W. K. et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl Acad. Sci. USA 105, 20458–20463 (2008).
Wan, J. C. M. et al. Liquid biopsies come of age: Towards implementation of circulating tumour DNA. Nat. Rev. Can. 17, 223–238 (2017).
Chan, K. C. A. et al. Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer. N. Engl. J. Med. 377, 513–522 (2017).
Lennon, A. M. et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science https://doi.org/10.1126/science.abb9601 (2020).
Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926–930 (2018).
Lam, W. K. J. et al. Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma. Proc. Natl Acad. Sci. USA 115, E5115–E5124 (2018).
Lam, W. K. J. et al. Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases. Nat. Commun. 10, 3256 (2019).
Sun, K. et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl Acad. Sci. USA 112, E5503–E5512 (2015).
Liu, M. C. et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31, 745–759 (2020).
Jiang, P. et al. Plasma DNA end motif profiling as a fragmentomic marker in cancer, pregnancy and transplantation. Cancer Discov. 10, 664–673 (2020).
Acknowledgements
The authors’ work is supported by the Hong Kong Research Grants Council Theme-Based Research Scheme (T12-401/16-W) and the Li Ka Shing Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Y.M.D.L. is a scientific co-founder, shareholder, scientific advisory board member and consultant of, and receives research support from, Grail. He is also a founder, shareholder and board member of the Take2 Group of companies and DRA Limited and an advisor of Decheng Capital. W.K.J.L. holds equity in Grail.
Rights and permissions
About this article
Cite this article
Lo, Y.M.D., Lam, W.K.J. Towards multi-cancer screening using liquid biopsies. Nat Rev Clin Oncol 17, 525–526 (2020). https://doi.org/10.1038/s41571-020-0404-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-020-0404-0
This article is cited by
-
Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome
Nature Reviews Clinical Oncology (2022)
